[
  {
    "ts": null,
    "headline": "Here's Why Moderna (MRNA) Fell More Than Broader Market",
    "summary": "In the most recent trading session, Moderna (MRNA) closed at $31.25, indicating a -2.95% shift from the previous trading day.",
    "url": "https://finnhub.io/api/news?id=34395eb5cc2cc36558203b6b02e7c90d9a4713c071adbf8d565f2b0bf8786f61",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752875404,
      "headline": "Here's Why Moderna (MRNA) Fell More Than Broader Market",
      "id": 136012267,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "In the most recent trading session, Moderna (MRNA) closed at $31.25, indicating a -2.95% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=34395eb5cc2cc36558203b6b02e7c90d9a4713c071adbf8d565f2b0bf8786f61"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know",
    "summary": "A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.",
    "url": "https://finnhub.io/api/news?id=27a815785e57b305eb8c9db61ad47f3107a578134bbf80b7c4b09171a751722b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752865852,
      "headline": "Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know",
      "id": 136012065,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.",
      "url": "https://finnhub.io/api/news?id=27a815785e57b305eb8c9db61ad47f3107a578134bbf80b7c4b09171a751722b"
    }
  },
  {
    "ts": null,
    "headline": "How IBM and Moderna’s partnership could lead to an explosion in drug development",
    "summary": "The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and treatments.",
    "url": "https://finnhub.io/api/news?id=dff06605ace43d4d60070ec4fecd815de9843a722609381b22b04b3623e02b45",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752862500,
      "headline": "How IBM and Moderna’s partnership could lead to an explosion in drug development",
      "id": 136019784,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and treatments.",
      "url": "https://finnhub.io/api/news?id=dff06605ace43d4d60070ec4fecd815de9843a722609381b22b04b3623e02b45"
    }
  }
]